<DOC>
	<DOCNO>NCT01797419</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics GS-5806 hospitalize infant RSV .</brief_summary>
	<brief_title>Safety Study GS-5806 Treat Respiratory Syncytial Virus ( RSV )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Respiratory Syncytial Virus Infections</mesh_term>
	<criteria>&lt; 24 month age Diagnosis Respiratory Syncytial Virus ( RSV ) within 48 hour screen Chronic congenital heart disease Required ventilation admission pediatric Intensive Care Unit Inadequate organ function</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Respiratory</keyword>
	<keyword>Syncytial</keyword>
	<keyword>Virus</keyword>
	<keyword>RSV</keyword>
</DOC>